Quotes 5-day view End-of-day quote Shanghai Stock Exchange
01/18/2021
01/19/2021
01/20/2021
01/21/2021
01/22/2021
Date
107.83
104.95
105.97
108.15
112.6
Last
23513190
34814220
30502720
38293450
41130790
Volume
-1.82% -2.67% +0.97% +2.06% +4.11% Change
Sales 2020
28 624 M 4 417 M 4 417 M
Net income 2020
6 433 M 993 M 993 M
Net cash position 2020
14 071 M 2 171 M 2 171 M
P/E ratio 2020
92,1x
Yield 2020
0,18%
Sales 2021
35 851 M 5 532 M 5 532 M
Net income 2021
8 210 M 1 267 M 1 267 M
Net cash position 2021
18 325 M 2 828 M 2 828 M
P/E ratio 2021
71,9x
Yield 2021
0,23%
Capitalization
598 B 92 231 M 92 238 M
EV / Sales 2020
20,4x
EV / Sales 2021
16,2x
Nbr of Employees
24 431
Free-Float
39,2%
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:
- anti-tumor drugs (No. 1 Chinese);
- Anesthetic drugs;
- contrast agents: used in medical imaging;
- anti-inflammatory drugs;
- drugs for the treatment of cardiovascular diseases.
Notations Surperformance© of Jiangsu Hengrui Medicine Co., Ltd.
Trading Rating : Investor Rating :
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
News in other languages on JIANGSU HENGRUI MEDICINE CO., LTD.
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
24
Average target price
108,71 CNY
Last Close Price
112,60 CNY
Spread / Highest target
14,6%
Spread / Average Target
-3,46%
Spread / Lowest Target
-33,5%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
